This research report focuses on the Gene Delivery Systems Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Viral Gene Delivery System
- 1.2.3 Non-viral Gene Delivery System
- 1.2.4 Combined Hybrid System
- 1.3 Market by Application
- 1.3.1 Global Gene Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Infectious Diseases
- 1.3.3 Oncology
- 1.3.4 Ophthalmology
- 1.3.5 Urology
- 1.3.6 Diabetes
- 1.3.7 CNS
- 1.3.8 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Gene Delivery Systems Market Perspective (2017-2028)
- 2.2 Gene Delivery Systems Growth Trends by Region
- 2.2.1 Gene Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Gene Delivery Systems Historic Market Size by Region (2017-2022)
- 2.2.3 Gene Delivery Systems Forecasted Market Size by Region (2023-2028)
- 2.3 Gene Delivery Systems Market Dynamics
- 2.3.1 Gene Delivery Systems Industry Trends
- 2.3.2 Gene Delivery Systems Market Drivers
- 2.3.3 Gene Delivery Systems Market Challenges
- 2.3.4 Gene Delivery Systems Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Gene Delivery Systems Players by Revenue
- 3.1.1 Global Top Gene Delivery Systems Players by Revenue (2017-2022)
- 3.1.2 Global Gene Delivery Systems Revenue Market Share by Players (2017-2022)
- 3.2 Global Gene Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Gene Delivery Systems Revenue
- 3.4 Global Gene Delivery Systems Market Concentration Ratio
- 3.4.1 Global Gene Delivery Systems Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery Systems Revenue in 2021
- 3.5 Gene Delivery Systems Key Players Head office and Area Served
- 3.6 Key Players Gene Delivery Systems Product Solution and Service
- 3.7 Date of Enter into Gene Delivery Systems Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Delivery Systems Breakdown Data by Type
- 4.1 Global Gene Delivery Systems Historic Market Size by Type (2017-2022)
- 4.2 Global Gene Delivery Systems Forecasted Market Size by Type (2023-2028)
5 Gene Delivery Systems Breakdown Data by Application
- 5.1 Global Gene Delivery Systems Historic Market Size by Application (2017-2022)
- 5.2 Global Gene Delivery Systems Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Gene Delivery Systems Market Size (2017-2028)
- 6.2 North America Gene Delivery Systems Market Size by Type
- 6.2.1 North America Gene Delivery Systems Market Size by Type (2017-2022)
- 6.2.2 North America Gene Delivery Systems Market Size by Type (2023-2028)
- 6.2.3 North America Gene Delivery Systems Market Share by Type (2017-2028)
- 6.3 North America Gene Delivery Systems Market Size by Application
- 6.3.1 North America Gene Delivery Systems Market Size by Application (2017-2022)
- 6.3.2 North America Gene Delivery Systems Market Size by Application (2023-2028)
- 6.3.3 North America Gene Delivery Systems Market Share by Application (2017-2028)
- 6.4 North America Gene Delivery Systems Market Size by Country
- 6.4.1 North America Gene Delivery Systems Market Size by Country (2017-2022)
- 6.4.2 North America Gene Delivery Systems Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Gene Delivery Systems Market Size (2017-2028)
- 7.2 Europe Gene Delivery Systems Market Size by Type
- 7.2.1 Europe Gene Delivery Systems Market Size by Type (2017-2022)
- 7.2.2 Europe Gene Delivery Systems Market Size by Type (2023-2028)
- 7.2.3 Europe Gene Delivery Systems Market Share by Type (2017-2028)
- 7.3 Europe Gene Delivery Systems Market Size by Application
- 7.3.1 Europe Gene Delivery Systems Market Size by Application (2017-2022)
- 7.3.2 Europe Gene Delivery Systems Market Size by Application (2023-2028)
- 7.3.3 Europe Gene Delivery Systems Market Share by Application (2017-2028)
- 7.4 Europe Gene Delivery Systems Market Size by Country
- 7.4.1 Europe Gene Delivery Systems Market Size by Country (2017-2022)
- 7.4.2 Europe Gene Delivery Systems Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Gene Delivery Systems Market Size (2017-2028)
- 8.2 Asia-Pacific Gene Delivery Systems Market Size by Type
- 8.2.1 Asia-Pacific Gene Delivery Systems Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Gene Delivery Systems Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Gene Delivery Systems Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Gene Delivery Systems Market Size by Application
- 8.3.1 Asia-Pacific Gene Delivery Systems Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Gene Delivery Systems Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Gene Delivery Systems Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Gene Delivery Systems Market Size by Region
- 8.4.1 Asia-Pacific Gene Delivery Systems Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Gene Delivery Systems Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Gene Delivery Systems Market Size (2017-2028)
- 9.2 Latin America Gene Delivery Systems Market Size by Type
- 9.2.1 Latin America Gene Delivery Systems Market Size by Type (2017-2022)
- 9.2.2 Latin America Gene Delivery Systems Market Size by Type (2023-2028)
- 9.2.3 Latin America Gene Delivery Systems Market Share by Type (2017-2028)
- 9.3 Latin America Gene Delivery Systems Market Size by Application
- 9.3.1 Latin America Gene Delivery Systems Market Size by Application (2017-2022)
- 9.3.2 Latin America Gene Delivery Systems Market Size by Application (2023-2028)
- 9.3.3 Latin America Gene Delivery Systems Market Share by Application (2017-2028)
- 9.4 Latin America Gene Delivery Systems Market Size by Country
- 9.4.1 Latin America Gene Delivery Systems Market Size by Country (2017-2022)
- 9.4.2 Latin America Gene Delivery Systems Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Gene Delivery Systems Market Size (2017-2028)
- 10.2 Middle East & Africa Gene Delivery Systems Market Size by Type
- 10.2.1 Middle East & Africa Gene Delivery Systems Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Gene Delivery Systems Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Gene Delivery Systems Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Gene Delivery Systems Market Size by Application
- 10.3.1 Middle East & Africa Gene Delivery Systems Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Gene Delivery Systems Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Gene Delivery Systems Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Gene Delivery Systems Market Size by Country
- 10.4.1 Middle East & Africa Gene Delivery Systems Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Gene Delivery Systems Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Novartis
- 11.1.1 Novartis Company Details
- 11.1.2 Novartis Business Overview
- 11.1.3 Novartis Gene Delivery Systems Introduction
- 11.1.4 Novartis Revenue in Gene Delivery Systems Business (2017-2022)
- 11.1.5 Novartis Recent Developments
- 11.2 Amgen
- 11.2.1 Amgen Company Details
- 11.2.2 Amgen Business Overview
- 11.2.3 Amgen Gene Delivery Systems Introduction
- 11.2.4 Amgen Revenue in Gene Delivery Systems Business (2017-2022)
- 11.2.5 Amgen Recent Developments
- 11.3 Oxford BioMedica
- 11.3.1 Oxford BioMedica Company Details
- 11.3.2 Oxford BioMedica Business Overview
- 11.3.3 Oxford BioMedica Gene Delivery Systems Introduction
- 11.3.4 Oxford BioMedica Revenue in Gene Delivery Systems Business (2017-2022)
- 11.3.5 Oxford BioMedica Recent Developments
- 11.4 SIBIONO
- 11.4.1 SIBIONO Company Details
- 11.4.2 SIBIONO Business Overview
- 11.4.3 SIBIONO Gene Delivery Systems Introduction
- 11.4.4 SIBIONO Revenue in Gene Delivery Systems Business (2017-2022)
- 11.4.5 SIBIONO Recent Developments
- 11.5 Shanghai Sunway Biotech
- 11.5.1 Shanghai Sunway Biotech Company Details
- 11.5.2 Shanghai Sunway Biotech Business Overview
- 11.5.3 Shanghai Sunway Biotech Gene Delivery Systems Introduction
- 11.5.4 Shanghai Sunway Biotech Revenue in Gene Delivery Systems Business (2017-2022)
- 11.5.5 Shanghai Sunway Biotech Recent Developments
- 11.6 Roche
- 11.6.1 Roche Company Details
- 11.6.2 Roche Business Overview
- 11.6.3 Roche Gene Delivery Systems Introduction
- 11.6.4 Roche Revenue in Gene Delivery Systems Business (2017-2022)
- 11.6.5 Roche Recent Developments
- 11.7 Pfizer
- 11.7.1 Pfizer Company Details
- 11.7.2 Pfizer Business Overview
- 11.7.3 Pfizer Gene Delivery Systems Introduction
- 11.7.4 Pfizer Revenue in Gene Delivery Systems Business (2017-2022)
- 11.7.5 Pfizer Recent Developments
- 11.8 Bayer
- 11.8.1 Bayer Company Details
- 11.8.2 Bayer Business Overview
- 11.8.3 Bayer Gene Delivery Systems Introduction
- 11.8.4 Bayer Revenue in Gene Delivery Systems Business (2017-2022)
- 11.8.5 Bayer Recent Developments
- 11.9 Johnson & Johnson
- 11.9.1 Johnson & Johnson Company Details
- 11.9.2 Johnson & Johnson Business Overview
- 11.9.3 Johnson & Johnson Gene Delivery Systems Introduction
- 11.9.4 Johnson & Johnson Revenue in Gene Delivery Systems Business (2017-2022)
- 11.9.5 Johnson & Johnson Recent Developments
- 11.10 Becton Dickinson
- 11.10.1 Becton Dickinson Company Details
- 11.10.2 Becton Dickinson Business Overview
- 11.10.3 Becton Dickinson Gene Delivery Systems Introduction
- 11.10.4 Becton Dickinson Revenue in Gene Delivery Systems Business (2017-2022)
- 11.10.5 Becton Dickinson Recent Developments
- 11.11 AstraZeneca
- 11.11.1 AstraZeneca Company Details
- 11.11.2 AstraZeneca Business Overview
- 11.11.3 AstraZeneca Gene Delivery Systems Introduction
- 11.11.4 AstraZeneca Revenue in Gene Delivery Systems Business (2017-2022)
- 11.11.5 AstraZeneca Recent Developments
- 11.12 Baxter
- 11.12.1 Baxter Company Details
- 11.12.2 Baxter Business Overview
- 11.12.3 Baxter Gene Delivery Systems Introduction
- 11.12.4 Baxter Revenue in Gene Delivery Systems Business (2017-2022)
- 11.12.5 Baxter Recent Developments
- 11.13 HSCI
- 11.13.1 HSCI Company Details
- 11.13.2 HSCI Business Overview
- 11.13.3 HSCI Gene Delivery Systems Introduction
- 11.13.4 HSCI Revenue in Gene Delivery Systems Business (2017-2022)
- 11.13.5 HSCI Recent Developments
- 11.14 Epeius Biotechnologies
- 11.14.1 Epeius Biotechnologies Company Details
- 11.14.2 Epeius Biotechnologies Business Overview
- 11.14.3 Epeius Biotechnologies Gene Delivery Systems Introduction
- 11.14.4 Epeius Biotechnologies Revenue in Gene Delivery Systems Business (2017-2022)
- 11.14.5 Epeius Biotechnologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer